Guide to using AAV vectors in gene therapy
Drug Discovery World
FEBRUARY 8, 2024
In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. Dr O’Hara added that when thinking about the AAV particles, they need to be quantified accurately for all downstream applications. This all creates numerous challenges for the market.
Let's personalize your content